[Uncertainly after publications on glitazones. Elevated myocardial infarction risk is not a class effect].
Erdmann
Erland
E
Herzzentrums der Universität zu Köln. erland.erdmann@uni-koeln.de
Scherbaum
Werner A
WA
D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000139:chemically induced*; D000077205:Pioglitazone; D011643:Publishing; D012307:Risk Factors; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000077205:Pioglitazone